We're sorry, but this page has no content yet.
Medical Device Lawsuit Alerts
- Petition for Inter Partes Review by Intuitive Surgical, Inc. of Ethicon LLC f/k/a Ethicon Endo-Surgery, LLC’s U.S. Patent No. 9,844,379 (Final Written Decision)
- Petition for Inter Partes Review by Edwards Lifesciences Corp. et al of Colibri Heart Valve LLC’s U.S. Patent No. 9,125,739 (Inter Partes Review Instituted)
- Petition for Inter Partes Review by Intuitive Surgical, Inc. of Rex Medical, LP’s U.S. Patent No. 9,439,650
- Petition for Inter Partes Review by New World Medical, Inc. of MicroSurgical Technology, Inc.’s U.S. Patent No. 10,123,905 (Inter Partes Review Instituted)
- Petition for Inter Partes Review by New World Medical, Inc. of MicroSurgical Technology, Inc.’s U.S. Patent No. 9,107,729 (Inter Partes Review Instituted)
Recent Medical Device News
- Siemens to acquire Varian for $16.4 Billion
- Presidio Medical Announces $30 Million Financing Round Led by Invus Opportunities
- Polares Medical Closes a $40M Financing to Complete Pilot Clinical Studies
- CVRx Raises $50 Million in New Equity Financing
- Medtronic Makes Offer for Medical Device Maker Intersect
FDA Taking Steps to Prevent Future Medical Device Shortages
By Paige Cappelli
According to the FDA, the medical device industry experienced significant supply chain disruptions during the COVID-19 pandemic. Such disruptions caused shortages of PPE, ventilators, diagnostic testing, and other medical devices. As Janet Woodcock, M.D., the Acting Commissioner of Food and Drugs, acknowledges in her July 21, 2021 statement: “the pandemic has exposed great weaknesses in the medical device supply chain and its dependence on foreign medical devices.” Woodcock also explains the steps being taken by the FDA to avoid such shortages in the future. One step includes a req...
According to the FDA, the medical device industry experienced significant supply chain disruptions during the COVID-19 pandemic. Such disruptions caused shortages of PPE, ventilators, diagnostic testing, and other medical devices. As Janet Woodcock, M.D., the Acting Commissioner of Food and Drugs, acknowledges in her July 21, 2021 statement: “the pandemic has exposed great weaknesses in the medical device supply chain and its dependence on foreign medical devices.” Woodcock also explains the steps being taken by the FDA to avoid such shortages in the future. One step includes a req...
Share